Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
RESEARCH TOOLSreports
Holding INSP?
Track your performance easily
INSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.00 - $257.40
Previous Close$179.82
Volume468.70K
Average Volume (3M)611.78K
Market Cap
$5.47B
Enterprise Value$5.06B
Total Cash (Recent Filing)$439.66M
Total Debt (Recent Filing)$24.51M
Price to Earnings (P/E)989.7
Beta0.97
Next Earnings
Oct 29, 2024EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding29,821,707
10 Day Avg. Volume374,732
30 Day Avg. Volume611,780
Standard Deviation0.16
R-Squared0.18
Alpha0.00946
Financial Highlights & Ratios
Price to Book (P/B)8.57
Price to Sales (P/S)7.75
Price to Cash Flow (P/CF)-17533.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.19
Enterprise Value/Gross Profit9.57
Enterprise Value/Ebitda945.98
Forecast
1Y Price Target
$213.25Price Target Upside18.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Inspire Medical Systems News
PremiumCompany Announcements
Inspire Medical Systems Enhances Investor Relations and Share Value
Bulls Say, Bears Say
Bulls Say
EarningsInspire Medical Systems, Inc. reported Q2 revenue of $195.9M, ahead of estimates from both the analyst and the Street.
Product ApprovalPositive recent developments include the FDA approval and upcoming limited release of the next-gen Inspire V system, which may reduce average OR times and free up additional capacity for surgeons.
Share Repurchase ProgramINSP announced a $150M share repurchase program, signaling management's continued confidence in their underlying business.
Bears Say
Commercial OutlookResults surpassing expectations could ultimately represent more of a commercial headwind for INSP than initially thought.
Revenue GuidanceINSP's updated revenue guidance for FY24 implies little-to-no upside for 2H24 sales vs. consensus coming into the quarter.
Surgeon CapacityINSP’s main bottleneck remains ENT surgeon capacity, especially as some other procedures pay better.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.00 and its highest was $257.40 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Currently, no data Available
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Oct 29, 2024 which is in 58 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Aug 06, 2024. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.46.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is $0.07.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,821,707 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.32 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went up 28.141%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Among the largest hedge funds holding Inspire Medical Systems’s share is Iron Triangle Partners LP. It holds Inspire Medical Systems’s shares valued at 38M.
---
Inspire Medical Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$213.25 (18.59% Upside)
$213.25 (18.59% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 518.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.30%
12-Months-Change
Fundamentals
Return on Equity
1.03%
Trailing 12-Months
Asset Growth
17.82%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
---
INSP Company Deck
---
INSP Earnings Call
Q2 2024
0:00 / 0:00
---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Month Forecast
Average Price Target
$213.25
▲(18.59% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
16/27 ratings generated profit
1 Year Average Return
+24.68%
assigned a buy rating 25 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 59.26% of your transactions generating a profit, with an average return of +24.68% per trade.
---